Femasys Inc. to Participate in Upcoming January Investor Conferences
December 23, 2021 08:05 ET
|
Femasys Inc.
ATLANTA, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally...
Femasys Inc. Announces Financial Results for the Third Quarter of 2021
November 10, 2021 16:05 ET
|
Femasys Inc.
-- Up to 792-patient, pivotal LOCAL trial progressing for FemaSeed® after receipt of investigational device exemption (IDE) submission approval -- -- Femasys added to the Russell...
Femasys Inc. to Present at The MedTech Conference
September 23, 2021 17:46 ET
|
Femasys Inc.
ATLANTA, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include...
Femasys Inc. To Join the Russell Microcap® Index
September 20, 2021 16:05 ET
|
Femasys Inc.
ATLANTA, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY) (“Femasys” or the “Company”), a biomedical company developing a suite of product candidates to transform women’s healthcare...
Femasys Inc. Announces the Appointment of Edward Evantash, M.D. as Chief Medical Officer
September 01, 2021 16:05 ET
|
Femasys Inc.
-- Industry veteran with over than two decades of experience in medical affairs to lead clinical and medical affairs at Femasys -- ATLANTA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:...
Femasys Inc. Announces Financial Results for the Second Quarter of 2021
August 11, 2021 16:05 ET
|
Femasys Inc.
Completed initial public offering (“IPO”) raising net proceeds of $31.6 millionAppointed Anne Morrissey to the Board of Directors, an industry expert with decades of medical device experienceInitiated...
Femasys Inc. Announces First Patient Treated in Pivotal Trial for FemaSeed
July 20, 2021 08:31 ET
|
Femasys Inc.
First in Class Insemination Treatment for Infertility LOCAL Pivotal Trial to Enroll Up to 792 Patients Across 20 U.S. Centers ATLANTA, July 20, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:...
Femasys Inc. Announces Appointment of New Board Member
June 24, 2021 10:54 ET
|
Femasys Inc.
ATLANTA, June 24, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on transforming women's healthcare, today announced the appointment of Anne Morrissey to the...
Femasys Inc. Announces Pricing of Initial Public Offering
June 17, 2021 20:00 ET
|
Femasys Inc.
ATLANTA, June 17, 2021 (GLOBE NEWSWIRE) -- Femasys Inc., a biomedical company focused on transforming women's healthcare by developing novel solutions and next-generation advancements providing...
Femasys Announces First 100 Women Treated in Pivotal Clinical Trial with FemBloc® Permanent Contraceptive System
January 04, 2019 09:13 ET
|
Femasys Inc.
ATLANTA, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Femasys, Inc., a medical technology company developing a platform of innovative in-office solutions for women’s healthcare today announced that the first...